| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Apr―01 |
Comparison of ELISA with automated ECLIA for IL-6 determination in COVID-19 patients: An Italian real-life experience |
Francesca Romano, Luisa Lanzilao, Edda Russo, Maria Infantino, Francesca Nencini, Giovanni Cappelli, et al. (+5) Stefano Dugheri, Mariangela Manfredi, Alessandra Fanelli, Amedeo Amedei, Nicola Mucci |
| 2 |
[GO] |
2023―Jul―03 |
Immune biomarkers associated with COVID-19 disease severity in an urban, hospitalized population |
Allison B. Chambliss, Mayada Aljehani, Brian Tran, Xingyao Chen, Elizabeth Elton, Carolina Garri, et al. (+3) Nolan Ung, Naim Matasci, Mitchell E. Gross |
| 3 |
[GO] |
2022―Jul―19 |
Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of Iraq |
Hussein Noori Ali, Kameran Mohammed Ali, Hassan Muhammad Rostam, Ayad M. Ali, Hassan Mohammad Tawfeeq, Mohammed Hassan Fatah, Grazziela P. Figueredo |
| 4 |
[GO] |
2022―Jul―07 |
Comparative performance of COVID-19 serology testing |
Nam K. Tran, Larissa May, Stuart H. Cohen, John Rodrigo, Raymond Gong, Ying Liu, Peter Conner |
| 5 |
[GO] |
2022―Jan―15 |
Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay |
Gian Luca Salvagno, Laura Pighi, Simone De Nitto, Giuseppe Lippi |
| 6 |
[GO] |
2021―Apr―28 |
PERFORMANCE OF AN AUTOMATED CHEMILUMINESCENT IMMUNOASSAY FOR SARS-COV-2 IgM AND HEAD-TO-HEAD COMPARISON OF ABBOTT AND ROCHE COVID-19 ANTIBODY ASSAYS |
Lau CS, Hoo SP, Liang YL, Phua SK, Aw TC |
| 7 |
[GO] |
2021―Apr―28 |
Analysis of SARS-CoV-2 Antibodies from Dried Blood Spot Samples with the Roche Elecsys Immunochemistry Method |
Elizabeth Fontaine, Cristian Saez |
| 8 |
[GO] |
2021―Apr―21 |
Comparison of virus neutralization activity and results of 10 different anti-SARS-CoV-2 serological tests in COVID-19 recovered plasma donors |
Zsófia Szabó, Tamás Szabó, Kornélia Bodó, Gábor Kemenesi, Fanni Földes, Katalin Kristóf, et al. (+7) Eszter Barabás, Barna Vásárhelyi, Zoltán Prohászka, Eszter Fodor, Ferenc Jakab, Timea Berki, Zsombor Lacza |
| 9 |
[GO] |
2021―Apr―21 |
Plasma LDH: A specific biomarker for lung affectation in COVID-19? |
Pablo Serrano-Lorenzo, Olga N. Coya, Ana López-Jimenez, Alberto Blázquez, Aitor Delmiro, Alejandro Lucía, et al. (+6) Joaquín Arenas, Miguel A. Martín, Alejandro Santos-Lozano, Cecilia Cueto-Felgueroso, Alba Fernández-del Pozo, Montserrat de Miguel-Reyes |
| 10 |
[GO] |
2021―Apr―20 |
Diagnostic perfomance of an automated chemiluminescence immunoassay for SARS-CoV-2 IgG and IgM antibodies detection: a real life experience |
Danilo Villalta, Paola Martelli, Anna Moratto, Valeria Salgarolo, Elita Ligato, Mariaelisabetta Conte, et al. (+5) Roberto Giacomello, Tommaso Pellis, Rita De Rosa, Sergio Venturini, Massimo Crapis |
| 11 |
[GO] |
2021―Feb―21 |
Longitudinal Evaluation of the Abbott Architect SARS-CoV-2 IgM and IgG Assays in a Pediatric Population |
Cristina Interiano, Sheicho Muze, Brian Turner, Mark Gonzalez, Beverly Rogers, Robert Jerris, et al. (+3) Elizabeth Weinzierl, Mohamed Elkhalifa, Van Leung-Pineda |
| 12 |
[GO] |
2021―Jan―19 |
PERFORMANCE OF TWO RAPID POINT OF CARE SARS-COV-2 ANTIBODY ASSAYS AGAINST LABORATORY-BASED AUTOMATED CHEMILUMINESCENT IMMUNOASSAYS FOR SARS-COV-2 IG-G, IG-M AND TOTAL ANTIBODIES |
Lau CS, Hoo SP, Liang YL, Phua SK, Aw TC |
| 13 |
[GO] |
2020―Oct―17 |
The challenge of producing an EQA for the COVID-19 pandemic |
Tony Badrick, Louise Wienholt, Daniel Fone, Derek Holzhauser |
|
